| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.7824 | 44 |
| GSM780708 | Untreated after 4 days (C2_1) | 49.284 | 46 |
| GSM780709 | Untreated after 4 days (C3_1) | 58.0427 | 63 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.0963 | 32 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.974 | 27 |
| GSM780721 | Untreated after 4 days (C3_2) | 62.9142 | 66 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 58.1853 | 63 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 50.2232 | 49 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 41.542 | 11 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 60.8023 | 65 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 51.1203 | 52 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 47.054 | 37 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 43.4483 | 19 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.3789 | 43 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 48.8297 | 44 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 48.8382 | 44 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 49.8065 | 48 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.2258 | 46 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 50.5901 | 50 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 53.3419 | 57 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.2867 | 33 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 50.0094 | 49 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.7423 | 44 |